Prognostic Significance of DNA Ploidy and Proliferative Index (MIB-1 Index) in Childhood Rhabdomyosarcoma

American Journal of Clinical Pathology

Volumn 121, Issue 3, 2004, Pages 358-365

  San Miguel Fraile, Pilar ^a,d   Carrillo Gijón, Rosario ^b   Rodriguez Peralto, Jose Luis ^c   Badiola, Iosu Antón ^a  

^a Department of Pathology ^*  (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d POVISA   (Spain)

Author keywords

DNA analysis; MIB 1; Prognostic factor; Rhabdomyosarcoma

Indexed keywords

DNA;

ADOLESCENT; ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DIPLOIDY; DNA CONTENT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERDIPLOIDY; HYPERPLOIDY; INFANT; MALE; MITOSIS INDEX; PLOIDY; POLYPLOIDY; PRIORITY JOURNAL; PROGNOSIS; PROLIFERATIVE INDEX; RHABDOMYOSARCOMA; TETRAPLOIDY; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DNA, NEOPLASM; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KI-67 ANTIGEN; MALE; PLOIDIES; PROGNOSIS; RHABDOMYOSARCOMA;

EID: 1542317801     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/3DD8-0UC4-DDJ0-JMT2     Document Type: Article

References (36)

1. Nakhleh RE, Swanson PE, Dehner LP, et al. Juvenile (embryonal and alveolar) rhabdomyosarcoma of the head and neck in adults; a clinical, pathologic and immunohistochemical study of 12 cases. Cancer. 1991;67:1019-1024.
2. Crist W, Gehan EA, Ragab AH, et al. The Intergroup Rhabdomyosarcoma Study III. J Clin Oncol. 1995;13:610-630.
3. Pappo S. Rhabdomyosarcoma and other soft tissue sarcomas of childhood. Curr Opin Oncol. 1995;7:361-366.
4. La Quaglia MP, Heller G, Ghavimi F, et al. The effect of age at diagnosis on outcome in rhabdomyosarcoma. Cancer. 1994;73:109-117.
5. Rodary C, Gehan EA, Flamant F, et al. Prognostic factors in 951 nonmetastatic rhabdomyosarcoma in children: a report from the International Rhabdomyosarcoma Workshop. Med Pediatr Oncol. 1991;19:89-95.
6. Qualman SJ, Coffin CM, Newton WA, et al. Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr Dev Pathol. 1998;1:550-561.
7. Lawrence WJ, Gehan EA, Hays DM, et al. Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS II). J Clin Oncol. 1987;5:46-54.
8. Maurer HM, Gehan EA, Beltangady M, et al. The Intergroup Rhabdomyosarcoma Study II. Cancer. 1993;71:1904-1922.
9. Pappo AS, Shapiro DN, Crist WM, et al. Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol. 1995;13:2123-2139.
10. Marshall T, Ruitedge JC. Flow cytometry DNA application in pediatric tumor pathology. Pediatr Dev Pathol. 2000;3:314-320.
11. Williams DL, Tsiatis A, Bradem GM, et al. Prognostic importance of chromosome number in 136 untreated children with acute lymphoblastic leukemia. Blood. 1982;60:864-871.
12. Boyle ET, Reiman HM, Kramer SA, et al. Embryonal rhabdomyosarcoma of bladder and prostate: nuclear DNA patterns studied by flow cytometry. J Urol. 1988;140:1119-1121.
13. Molenaar WM, Dam-meiring A, Kamps WA, et al. DNA-aneuploidy in rhabdomyosarcoma as compared with other sarcomas of childhood and adolescence. Hum Pathol. 1988;5:573-578.
14. Kowal-Vern A, Gonzalez Crussi F, Turner J, et al. Flow and image cytometric DNA analysis in rhabdomyosarcoma. Cancer Res. 1990;50:6023-6027.
15. Leuschner I, Newton WA, Schmidt D, et al. Spindle cell rhabdomyosarcoma: a prognostically favorable variant of rhabdomyosarcoma. Am J Surg Pathol. 1993;16:229-235.
16. Dias P, Kumar P, Marsden HB, et al. Prognostic relevance of DNA ploidy in rhabdomyosarcomas and other sarcomas of childhood. Anticancer Res. 1992;12:1173-1177.
17. El-Naggar A, Batsakis JG, Ordoñez NG. Rhabdomyosarcoma of the adult head and neck: a clinicopathological and DNA ploidy study. J Laryngol Otol. 1993;107:716-720.
18. Kilpatrick SE, Teot LA, Geisinger KR, et al. Relationship of DNA ploidy to histology and prognosis in rhabdomyosarcoma: comparison of flow cytometry and image analysis. Cancer. 1994;74:3227-3233.
19. Pappo AS, Crist WM, Kuttesch J, et al. Tumor cell DNA content predicts outcome in children and adolescents with clinical group III embryonal rhabdomyosarcoma. J Clin Oncol. 1993;11:1901-1905.
20. Shapiro DM, Parham DM, Douglass EC. Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma. J Clin Oncol. 1991;9:159-166.
21. Wijnaendts LCD, ven del Linden JC, van Diest PJ, et al. Prognostic importance of DNA flow cytometric variables in rhabdomyosarcomas. J Clin Pathol. 1993;46:948-952.
22. Niggli FK, Powel JE, Parkes SE, et al. DNA ploidy and proliferative activity (S-phase) in childhood soft-tissue sarcomas: their value as prognostic indicators. Br J Cancer. 1994;69:1106-1110.
23. De Zen L, Sommaggio A, d'Amore ESG, et al. Clinical relevance of DNA ploidy and proliferative activity in childhood rhabdomyosarcoma: a retrospective analysis of patients enrolled into the Italian Cooperative Rhabdomyosarcoma Study RMS88. J Clin Oncol. 1997;15:1198-1205.
24. Raney RB, Donaldson MH, Sutow WW, et al. Special considerations related to primary site in rhabdomyosarcoma: experience of the Intergroup Rhabdomyosarcoma Study, 1972-1976. Natl Cancer Inst Monogr. 1981;56:69-74.
25. Tsokos M, Webber BL, Parham DM, et al. Rhabdomyosarcoma: a new classification scheme related to prognosis. Arch Pathol Lab Med. 1992;116:847-855.
26. Lawrence W, Gehan EA, Hays DM, et al. Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS-II). J Clin Oncol. 1987;5:46-54.
27. Flamant F, Rodary C, Rey A, et al. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence: results of the second study of the International Society of Pediatric Oncology: MMT84. Eur J Cancer. 1998;34:1052-1062.
28. Stewart RJ, Martelli H, Oberlin O, et al. Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT84 and MMT89) of the International Society of Pediatric Oncology. J Clin Oncol. 2003;21:793-798.
29. Newton WA, Gehan EA, Webber BL, et al. Classification of rhabdomyosarcoma and related sarcomas, pathologic aspects and proposal for a new classification: an Intergroup Rhabdomyosarcoma Study. Cancer. 1995;76:1073-1085.
30. Hedley DW, Friedlander ML, Taylor IW. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry. 1985;6:327-333.
31. Abraira V, Zaplana J. PRESTA: un paquete de procesamientos estadísticos. Proceedings de la Conferencia Iberoamericana de Bioingeniería. Asturias, Spain: Gijón; 1984:100.
32. Weiss SW, Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors. 4th ed. St Louis, MO: Mosby-Year Book; 2001:785-835.
33. Look AT, Hayes FA, Nitschke R, et al. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med. 1984;311:231-235.
34. Oppedal BR, Glomstein A, Zetterberg A. Feulgen DNA values in Wilms' tumour in relation to prognosis. Pathol Res Pract. 1998;183:756-760.
35. Carrillo R, Candia A, Rodriguez Peralto JL, et al. Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors. Hum Pathol. 1997;28:160-165.
36. Noguchi S, Tamiya S, Nagoshi M, et al. Nuclear morphometry and the MIB-1 index in rhabdomyosarcoma. Mod Pathol. 1996;9:253-260.